N
Norihiro Kokudo
Researcher at University of Tokyo
Publications - 918
Citations - 39158
Norihiro Kokudo is an academic researcher from University of Tokyo. The author has contributed to research in topics: Liver transplantation & Hepatectomy. The author has an hindex of 86, co-authored 849 publications receiving 32035 citations. Previous affiliations of Norihiro Kokudo include Juntendo University & Meikai University.
Papers
More filters
Journal ArticleDOI
Effects of body mass index (BMI) on surgical outcomes: a nationwide survey using a Japanese web-based database
Motonari Ri,Hiroaki Miyata,Susumu Aikou,Yasuyuki Seto,Kohei Akazawa,Masahiro Takeuchi,Yoshiro Matsui,Hiroyuki Konno,Mitsukazu Gotoh,Masaki Mori,Noboru Motomura,Shinichi Takamoto,Yoshiki Sawa,Hiroyuki Kuwano,Norihiro Kokudo +14 more
TL;DR: This Japanese nationwide study provides solid evidence to reinforce that both obesity and excessively low weight are factors that impact operative outcomes significantly.
Journal ArticleDOI
Correlation Between Contrast-Enhanced Intraoperative Ultrasound Using Sonazoid and Histologic Grade of Resected Hepatocellular Carcinoma
Junichi Arita,Kiyoshi Hasegawa,Michiro Takahashi,Shojiro Hata,Junichi Shindoh,Yasuhiko Sugawara,Norihiro Kokudo +6 more
TL;DR: In this article, the correlation between findings of contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of hepatocellular carcinoma (HCC) was accurately assessed.
Journal ArticleDOI
Clinical implication of hypovascular hepatocellular carcinoma studied in 4,474 patients with solitary tumour equal or less than 3 cm.
Kenichi Takayasu,Shigeki Arii,Michiie Sakamoto,Yutaka Matsuyama,Masatoshi Kudo,Takafumi Ichida,Osamu Nakashima,Osamu Matsui,Namiki Izumi,Yonson Ku,Norihiro Kokudo,Masatoshi Makuuchi +11 more
TL;DR: To clarify the biological behaviour of small hypovascular hepatocellular carcinoma (HCC) because of insufficient evidence even though frequently encountered.
Journal Article
Novel aminopeptidase N (APN/CD13) inhibitor 24F can suppress invasion of hepatocellular carcinoma cells as well as angiogenesis.
TL;DR: Anti-cancer effects of a hydroxamic acid derivative 24F that was newly-synthesized as an APN inhibitor had the ability to inhibit the invasion of hepatocellular carcinoma (HCC) cell line HuH-7, although the growth of HCC was not significantly inhibited at the analyzed concentrations of 24F and incubation times used.
Journal ArticleDOI
Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence.
Baasanjav Uranbileg,Hitoshi Ikeda,Makoto Kurano,Kenichiro Enooku,Masaya Sato,Daisuke Saigusa,Junken Aoki,Takeaki Ishizawa,Kiyoshi Hasegawa,Norihiro Kokudo,Yutaka Yatomi +10 more
TL;DR: Increased SK and SPL mRNA expression along with reduced S1P levels were more commonly observed in HCC tissues compared with adjacent non-HCC tissues and were associated with poor differentiation and early recurrence.